Expression of the melanocortin receptor (MC2R) gene is limited to adrenocortical cells and the aim of this study was to determine the factors responsible for this tissue specificity. We used different fragments of the human (h) MC2R gene promoter, inserted in a vector upstream of the luciferase reporter gene, to transiently transfect either bovine adrenocortical (BAC) cells or granulosa cells from bovine ovaries (B-Gran). Similar promoter activities were obtained in both cell types using constructs containing fragments up to 1017 bp of the hMC2R gene promoter. On the contrary, a 2-fold decrease was obtained after transfection of the B-Gran cells with vectors containing 1069 bp and more of the promoter. Results obtained here using BAC cells confirmed our previous data on human cells showing that steroidogenic factor 1 is the major transactivating factor involved in the basal expression of the hMC2R gene in adrenal cells. However, we showed that this factor did not permit, by itself, the expression of the hMC2R gene in B-Gran cells despite its expression in these cells. This study demonstrated for the first time that an E-box (located at −1020 bp) is involved in the repression of hMC2R gene expression in granulosa cells through interactions with several factors, such as activator protein 4, as suggested by electrophoretic mobility shift assay analyses.
Introduction
The adrenocorticotrophin (ACTH) receptor or melanocortin receptor type 2 (hMC2R) represents a good example of a cell-specifically regulated gene as it is expressed almost exclusively in the adrenocortical gland. There is one report of the presence of MC2R mRNA in human skin, using RT-PCR, but no evidence of the presence of the receptor itself (Slominski et al. 1996) . In the mouse the MC2R gene is also expressed in adipose tissue. This has been shown by demonstrating the presence of binding sites for labelled ACTH (Grunfeld et al. 1985) and by RT-PCR and Northern analysis (Boston & Cone 1996) . But levels of expression are limited in this tissue when compared with the levels present in mouse adrenal tissue. On the contrary, there is no evidence of the presence of MC2R in human adipocytes as its mRNA cannot be detected by RT-PCR (Cammas & Clark 1995) . The question which must be considered is the nature of the cis-regulatory elements and nuclear factors that control this adrenal expression of the MC2R gene.
In primary cultured human adrenal fasciculatareticularis cells, hMC2R is positively regulated by both ACTH and angiotensin-II, showing an increase in ACTH receptor number and mRNA accumulation (Lebrethon et al. 1994) . Among the transcription factors necessary for the expression of the human MC2R gene are the steroidogenic factor 1 (SF-1) which is involved both in constitutive and cAMP-controlled expression (Marchal et al. 1998 , Naville et al. 1999 and activator protein (AP-1) which is involved in angiotensin II-stimulated expression (Naville et al. 2001) . SF-1 also acts as a positive factor on mouse MC2R gene expression (Cammas et al. 1997) . It has been postulated that SF-1 could play a role in the cell-specific expression of the hMC2R gene but, as it is present in all steroidogenic cells, it cannot be the only factor involved and could possibly act by co-operation with other factors. At this time, there is no record of such factors which could mediate the tissuespecific expression of the hMC2R gene.
The aim of this study was to map other regulatory elements which could be involved in the cell-specific expression of the hMC2R gene. These might be binding sites for factors either permitting efficient expression of the hMC2R gene in adrenal cells and/or inhibiting its expression in all other tissues. For this purpose, we used two different types of cells which both express SF-1: bovine adrenocortical and granulosa cells in primary culture, the latter ones showing no expression of the MC2R gene. We have demonstrated here the presence of one region which is partially responsible for the cell-specific expression of hMC2R. This region contains an E-box which binds factor(s) with inhibitory functions in granulosa cells.
Materials and methods

Materials
Penicillin, streptomycin, nystatin, fetal calf serum (FCS), trypsin, ITS (10 mg/l insulin, 5·5 mg/l transferrin and 5 µg/l selenium), Dulbecco's modified Eagle's medium/Ham's nutrient mixture F-12 (DMEM/F-12; 15 mM HEPES), McCoy's 5A medium and restriction enzymes were purchased from Invitrogen (Cergy-Pontoise, France). Oligonucleotides were prepared by Sigma-Genosys (Cambridge, Cambs, UK).
Cell culture
Primary cultures of bovine adrenal fasciculatareticularis adrenal (BAC) cells were prepared by sequential treatment of adrenal cortical slices with trypsin (0·15%) as previously described (Derrien et al. 1996) . The cells were cultured in a chemically defined medium (DMEM/F-12) supplemented with 1% ITS and vitamin C (10 4 M). Primary cultures of bovine granulosa (B-Gran) cells were prepared from ovaries after the collection of large follicles (Lauber et al. 1993) . Briefly, the follicular fluid was aspirated and granulosa cells were scraped out using a plastic loop. The cells were cultured in McCoy's 5A medium supplemented with 1% ITS and 2·5% FCS.
The HEK293 (human embryonic kidney) cell line was cultured in DMEM/F-12 supplemented with 7·5% FCS.
All complete media contained penicillin (100 U/ml), streptomycin (0·1 mg/ml) and nystatin (20 U/ml).
Reporter vector constructions
All constructs were obtained in pGL3 basic which contains the firefly luciferase reporter gene (Promega, Charbonniè res, France) as previously described (Naville et al. 1999 (Naville et al. , 2001 ). The constructs which contain fragments between 1221 and 1069 bp were prepared by appropriate digestions of the p( 2248/+22)luc vector. Vectors containing mutated fragments were obtained using the QuickChange site-directed mutagenesis kit from Stratagene (Ozyme; Montigny-le-Bretonneux, France) and oligonucleotides containing the desired mutation (Table 1) . For each construct, at least two different preparations were performed and the same vectors were used for both cell types to rule out plasmid preparation inequalities.
Transient transfections and luciferase assays
The day before transfection, cells were plated on six-well dishes at 600 000 cells per well for BAC and B-Gran cells and 200 000 cells per well for HEK293 in complete medium. Transfections were performed in serum-free medium without antibiotics using the lipofectAMINE PLUS reagent (Invitrogen) in the presence of 2µg DNA, following the method suggested by the manufacturer. Luciferase activity was measured 3 days after transfection as previously described (Naville et al. 1999) . To assess transfection efficiency, cells were transfected with the pGL3 control vector which contains the SV40 promoter upstream of the luciferase gene. Moreover, in the first experiments, cells were co-transfected with the pRL-TK vector (Promega) which contains the Renilla luciferase reporter gene driven by the HSV-TK promoter, in order to normalize transfection efficiencies.
Statistical analysis was performed with Student's t-test for comparison between two groups. The null hypothesis was rejected when P.0·05 was obtained.
Electrophoretic mobility shift assay (EMSA)
Crude nuclear protein extracts were prepared from BAC and B-Gran cells as described by Schreiber et al. (1989) and the protein concentrations were determined by the BCA protein assay system (Pierce Chemical, Montluçon, France). Doublestranded oligonucleotides (Table 1) were labelled by T4 polynucleotide kinase (Invitrogen) using [ 32 -P]ATP (Amersham France, Saclay, France) and incubated with nuclear extracts as previously described (Naville et al. 1999) . Poly (dI.dC) (dI.dC) (Amersham France) was used as non-specific competitor to reduce non-specific binding to the probe. For the competition assays, a molar excess of 200-fold of unlabelled double-stranded oligonucleotides was added to the reaction mixture. The AP4sv oligonucleotide was designed from the sequence described by Mermod et al. (1988) . The resulting DNA-protein complexes were analyzed by electrophoresis as previously described (Naville et al. 1999) and dried gels were exposed to Kodak BioMax MR film (Sigma-Aldrich, Saint-Quentin Fallavier, France).
RT-PCR analysis
In order to determine the presence of activating enhancer-binding protein 4 (AP-4) mRNA in the adrenal gland and in granulosa cells, total RNA was prepared from various tissues or cells: BAC, B-Gran cells, human adrenocortical H295R cell line, human adrenal tissue and human granulosa cells using the method of Chomczynski & Sacchi (1987) . Human adult adrenals were obtained after organ removal for transplantation from brain-dead patients, with the approval of the ethical committee of the Hospices Civils de Lyon.
Reverse transcription was performed using total RNA. First-strand cDNA was prepared with 1µg RNA using M-MLV reverse transcriptase (Invitrogen) according to the manufacturer's protocol. One microlitre of reverse-transcribed cDNA was used for PCR reactions.
The primers used in the PCR reaction (38 cycles) were designed to amplify part (270 bp) of the human coding sequence (Genbank accession number: NM_003223) as the bovine sequence was not available.
Results
Deletion and mutation analyses of the hMC2R promoter in adrenal and non-adrenal cells
The transfection efficiencies were equivalent in BAC and B-Gran cells as demonstrated by using the pGL3 control vector: 307·7 69·3-and 421·9 116·0-fold stimulation over pGL3 (n=5) for BAC and B-Gran cells respectively. We used series of deleted fragments of the hMC2R gene promoter (from 63 to 2248 bp upstream of the transcription start site) inserted into a vector with luciferase gene as reporter, to transfect three different cell types ( 
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but not hMC2R gene (B-Gran cells) and cells expressing neither SF-1 nor hMC2R genes (HEK293). In BAC cells, luciferase activity increased by 5-fold as compared with pGL3 basic, using the shortest construct p( 63/+22)luc. After transfection with longer constructs, constitutive activities were significantly increased with a plateau obtained using constructs containing 503 bp of the promoter and more. On the contrary, in B-Gran cells all the constructs produced the same luciferase activities (around 13-fold increase above the level obtained with pGL3 basic) except the longest construction, p( 2248/+22)luc, which produced a 2-fold decreased activity as compared with the level of activity obtained with p( 1017/+22)luc vector. This would imply that part of inhibition of the hMC2R gene expression in B-Gran cells is dependent on cis-acting sequence(s) present between 1017 and 2248 bp upstream of the transcription start site. For HEK293 cells, the constitutive expression of hMC2R gene was very low (1·7-fold increase using the p( 1017/+22)luc vector) and even decreased when the cells were transfected with p( 2248/+22)luc (Fig. 1 ). As these non-steroidogenic cells do not express SF-1, could this factor be responsible for the constitutive expression of the hMC2R gene observed in B-Gran cells using constructs containing up to 1017 bp? Indeed, previous studies have already demonstrated that SF-1 is responsible for basal expression of the hMC2R gene in mouse Y1 and human adrenocortical H295R cell lines (Marchal et al. 1998 , Naville et al. 1999 .
Role of SF-1 in tissue-specific expression
To answer the question as to the role of SF-1 in tissue-specific expression, we mutated the core sequence of the three SF-1-binding sites in the context of either p( 263/+22)luc or p( 1017/ +22)luc (Naville et al. 1999) . These sites are located at 35, 98 and 209 bp from the transcription start site. As shown in Fig. 2A , mutation of the SF-1-binding sites induced a decrease of basal luciferase activity in BAC cells. This decrease was more pronounced when the mutations were induced within the longer construct (60%) compared with the mutated p( 263/+22)luc vector (44%). On the contrary, there was no change of activity in B-Gran cells using mutated p( 1017/ +22)luc and even a slight, but non-significant, increase of the activity when using mutated p( 263/+22)luc (Fig. 2B) . Nevertheless, SF-1 expressed in granulosa cells as in BAC cells was able to bind the three sites present in the hMC2R gene promoter using EMSA (data not shown), indicating that this binding was not sufficient to permit efficient expression of the hMC2R gene in B-Gran cells. All these results would imply that SF-1 was partly involved in the basal adrenalspecific expression of hMC2R in BAC cells, but not in the hMC2R gene expression obtained in non-adrenal cells using short fragments of the hMC2R gene promoter. Thus, the question arises as to which proximal region could allow this atypical expression.
The presence of an initiator element (Inr) in the hMC2R gene promoter, overlapping the transcription start site, has been described previously (Naville et al. 1997) . When mutated (Table 1) in the context of p( 263/+22)luc (Fig. 2) , there was a dramatic inhibition of luciferase activity obtained using B-Gran cells (80% decrease; Fig. 2B ). The decrease was less pronounced in BAC cells (45%). A combination of mutations (Inr mut/3SF1 mut) intensified the inhibition of expression in BAC but not in B-Gran cells, when compared with the value obtained with the Inr mut vector. Taken together, these results demonstrated that the atypical expression of hMC2R gene in B-Gran cells using proximal promoter could be explained mostly by the presence of the Inr element, whereas SF-1-binding sites play no major role.
Involvement of one E-box-containing element in the partial repression of hMC2R gene expression
From the results described above, we could postulate that other factors which bind sequences located between 1017 and 2248 bp are involved in this tissue-specific expression (Fig. 1) . These sequences could be further restricted to a region between 1069 bp and 1017 bp using other deleted constructs (Fig. 3A) . After transfection with the p( 1069/+22)luc vector, the basal luciferase activity relative to p( 1017/+22)luc vector was significantly (P,0·01) increased by 45% in BAC but, on the contrary, decreased by 40% in B-Gran cells. This indicates a strong difference (about 60%) in luciferase activity between BAC and B-Gran cells using this construct (Fig. 3A) . Similar results were obtained using vectors containing fragments up to 1221 bp of the promoter. In the sequence between 1069 and 1017 bp, several putative binding sites for known transcription factors are present. Interestingly, a consensus E-box (CAGCTG) is located at 1020 bp upstream of the transcription start site and therefore is truncated in the p( 1017/ +22)luc vector (Fig. 3B) . By directed mutagenesis, this E-box was completely disrupted (Table 1) in the context of the p( 1221/+22)luc vector. After transfection of this mutated construct, basal luciferase activity was differentially modified depending on the cell type: decreased in BAC and increased in B-Gran cells to values which were not significantly different from those obtained with p( 1017/+22)luc vector (Fig. 3A) . Differences obtained in luciferase activities using p( 1221/ +22)luc vector compared with p( 1017/+22)luc vector were then greatly reduced between BAC and B-Gran cells when the E-box was mutated. These results would be in favour of an inhibitory factor present in B-Gran cells that bound to the E-box and would be partially responsible for the absence of expression of the hMC2R gene in B-Gran cells. On the contrary, factors which bound the E-box in fasciculata-reticularis cells could have an activating function.
Other systematic mutations have been introduced in the context of the p( 1221/+22)luc vector between 1069 and 1017 bp, but only one mutation (Table 1) called mut Oc (mutation in a putative octamer (Oct)-binding site overlapping the E-box; Fig. 3B ) changed the basal activities in BAC and B-Gran cells, giving similar results to those obtained using a vector mutated within the E-box (Fig. 3A) . These results suggested that this region was also involved in the inhibition of the expression of the hMC2R gene in B-Gran cells.
Analysis of the E-box-containing region by EMSA
From the results above, we can conclude that the region 1069/ 1017 seems to contain silencer element(s) which would bind a repressor present in granulosa cells and partially prevent the expression of hMC2R gene in these cells, whereas a factor with activating function would bind to this region in BAC cells. It was therefore interesting to investigate this element further. We used the oligonucleotide SpE ( 1036/ 1003 in Table 1) containing the E-box as probe in a gel shift assay using nuclear extracts prepared from BAC and B-Gran cells in primary cultures. As shown in Fig. 4 , several complexes were obtained using each cell type and the patterns were different depending on the cell type. Complex 'c' migrated at the same mobility for both cell extracts but was more intense using B-Gran cell extracts. Complexes 'b' and 'd' were specifically formed with BAC and B-Gran cell extracts respectively. Complex 'a' was in fact a composite of two different complexes in both cell types with band 'a1' much less pronounced using BAC extracts or even absent in some gel shift experiments (Figs 5 and 6), when band 'a2' was mostly present in BAC nuclear extracts (Fig. 6 ). All nuclear proteins are specifically bound to this DNA sequence as the intensities of the bands were highly reduced after incubation with an excess of unlabelled SpE probe (Fig. 4) . In the presence of an excess of SpE mut Eb (Table 1) , where the E-box was mutated, band 'a2' was decreased using BAC cell nuclear extracts only but there was no modification of bands 'a1', 'b', 'c' and 'd' using both BAC and B-Gran cell extracts. This would imply that the specific formation of these last complexes needs a conserved E-box. To sum up these results, using the SpE probe, a complex 'b' was obtained specifically using BAC cell extracts, when two different complexes, 'a1' and 'd', appeared specifically using B-Gran cell Figure 4 Gel shift assay using −1036/−1003 probe. Gel shift was performed with nuclear extracts isolated from BAC and B-Gran cells, in the presence of the labelled probe SpE alone (lanes 1 and 4) or in the additional presence of a 200-fold excess of unlabelled probe SpE (lanes 2 and 5) or of a 200-fold excess of mutated SpE mut Eb (lanes 3 and 6). FP, free probe. In this figure, the bands corresponding to the unbound probe have been lost due to the long run performed to better separate the different bands.
Figure 5
Effect of ACTH on binding to the −1036/−1003 probe. Gel shift was performed using the labelled SpE probe, in the presence of nuclear extracts isolated from BAC cells treated (lanes 4 and 5) or not (lanes 2 and 3) with 10 −9 M ACTH. Lanes 3 and 5 were performed in the additional presence of an excess of unlabelled SpE. Lane 1 corresponds to the free probe.
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extracts. However, the formation of these different cell-specific complexes needed a conserved E-box.
Complexes 'b' and 'c' are the major ones obtained using BAC nuclear extracts. The adrenalspecific complex 'b' was positively regulated by a 48-h treatment in the presence of 10 9 M ACTH, when complexes 'a' and 'c' were not changed (Fig. 5) . Quantification of the bands indicated a 2-fold increase of the complex 'b' intensity after ACTH treatment (1·9 0·4-fold, using three different experiments).
When the mutated oligonucleotide SpE mut Eb was used as a labelled probe (Fig. 6 ) the intensity of the band 'a1' was greatly reduced in B-Gran cell extracts whereas the intensity of a lower band ('a2') increased. This complex 'a2' also increased in BAC cell extracts. The other bands ('b', 'c' and 'd') were not present using both cell extracts. These results confirmed that the formation of these complexes 'b' and 'c' for BAC cells and 'a1', 'c' and 'd' for B-Gran cells needs a conserved E-box. On the contrary, when the oligonucleotide SpE mut Oc (Table 1) was used as probe only the band 'a1' was present (Fig. 6) .
Again, all the other bands ('a2', 'b', 'c' and 'd') were absent. Formation of these complexes 'b' and 'c' for BAC cells and 'c' and 'd' for B-Gran cells needed conservation of both the E-box and the Oct sequence whereas formation of complex 'a1' needed a conserved E-box and a conserved Oct sequence was necessary for complex 'a2'.
It is known that upstream stimulatory factors (USF)-1 and USF-2 can bind to an E-box (CACGTG). Antibodies against either USF-1 or USF-2 did not generate super-shifted bands and did not diminish the intensity of bands in gel shift assay (data not shown), indicating that these factors were not part of the different complexes. Another factor (AP-4) has been described to bind the same sequence as the E-box found here (CAGCTG). Instead of using AP-4 antibodies, which are not commercially available, we used an oligonucleotide previously mentioned to bind this factor as unlabelled competitor. This AP4sv oligonucleotide (Table 1 ) was able to displace the complexes 'a1' present in B-Gran cell extracts (Fig. 7) indicating that the AP-4 transcription factor (or a related factor) could be part of the 'a1' complex. Indeed, AP-4 was expressed in both BAC and B-Gran cells as demonstated by RT-PCR (Fig. 8A) . AP-4 mRNA was also present in human adrenal tissue, in the human adrenocortical cell line H295R and in human granulosa cells (Fig. 8B) .
The AP4sv was also used as a labelled probe in the presence of nuclear extracts prepared from both BAC and B-Gran cells. A unique labelled complex was observed for both cell extracts with a mobility corresponding to the 'a1' band even in BAC cells, whereas this band was almost absent using nuclear Figure 7 Gel shift assay using the oligonucleotide AP4sv as competitor and probe. Gel shift assays were performed with nuclear extracts isolated from BAC and B-Gran cells, using as probe either labelled SpE (lanes 1-4) or labelled AP-4 (lanes 5-8), in the additional presence of an excess of unlabelled SpE (lanes 3 and 8) or unlabelled AP4sv containing an AP-4 binding sequence (lanes 4 and 7) . Lanes 1 and 5 correspond to the free probes. Tissue-specific expression of hMC2R gene · A BLONDET and others 819 extracts prepared from this latter cell type in the presence of the labelled SpE probe. These results confirmed that the BAC cell extracts contain AP-4 but that binding of protein(s) contained in complex 'b' (absent in B-Gran cell extract) could prevent the AP-4 binding to the SpE probe.
Discussion
To investigate the question as to which cis-acting elements of the hMC2R gene promoter are responsible for tissue-specific expression, we compared activities obtained after transient transfection of two types of steroidogenic cells. The models used were primary cultures of BAC and B-Gran cells. In fact we could not dispose easily of the equivalent human cells and there is no human non-adrenal cell line with well-preserved steroidogenic functions. Moreover, BAC cells display similar luciferase activities to H295R cells used previously (Naville et al. 2001) when transfected with deleted fragments of the hMC2R gene promoter inserted upstream of the luciferase gene.
The expression of the hMC2R gene seems to be controlled at several levels. The first one involves proximal sites present on the gene promoter which bind SF-1, as mutation of these sites induced a 60% decrease of basal expression in BAC cells. A similar decrease has been obtained using the mouse MC2R promoter displaying a mutated 25-SF-1-binding site (Cammas et al. 1997) . This factor is an important trans-activator in the expression of numerous genes in both adrenal and non-adrenal steroidogenic cells. In the adrenal, besides the expression of the MC2R gene (Cammas et al. 1997 , Marchal et al. 1998 , Naville et al. 1999 , it controls the expression of steroidogenic enzymes such as cholesterol side-chain cleavage promoter (P450 scc) (Liu & Simpson 1997) , 17 -hydroxylase/c17-20 lyase (Zhang & Mellon 1996) and 3 -hydroxysteroid dehydrogenase (Leers-Sucheta et al. 1997) or other target genes such as steroidogenic acute regulatory protein (Sugarawa et al. 1997) . In granulosa cells, SF-1 is involved in the regulation of expression of genes either expressed in granulosa and in adrenal cells such as P450 scc (Clemens et al. 1994) or expressed in granulosa cells but not in adrenal cells such as aromatase (Lynch et al. 1993) . But, as reported here, the binding of SF-1 to its responsive element is not sufficient to permit trans-activation of the MC2R gene expression in granulosa cells. In these cells, there was no difference in proximal hMC2R gene promoter activity in the presence of either wild-type SF-1-binding sites or mutated ones. The presence of the Inr element could explain the hMC2R gene expression retained by B-Gran cells after transfection with constructs containing only the proximal region downstream of position 1017 bp of the hMC2R gene promoter. This absence of transactivation by SF-1 in B-Gran cells at the hMC2R gene promoter level could be due to interaction with some co-repressor in these cells. Indeed, it is well known that SF-1 can interact with different cofactors, either co-activators such as CREB binding protein, cAMP responsive element binding protein (CREB)-binding protein (Carlone & Richards 1997) or co-repressors such as Dax-1 and nuclear corepressor (Crawford et al. 1998 ) which can modulate gene expression. SF-1 is also able to interact with several transcription factors such as selective promotor factor-1 (Liu & Simpson 1997) . In the case of the hMC2R gene, disruption of the SF-1-binding sites induced a more pronounced inhibition of expression when adrenal cells are transfected with a mutated p( 1017/+22)luc vector (60% inhibition) compared with mutated p( 263/+22)luc vector (44% inhibition). These results are in favour of the existence of an interaction between SF-1 and other factor(s), which would bind sites present between 263 and 1017, directly or through an intermediate protein. This activating factor may be present only in adrenal cells but not in granulosa or other non-adrenal steroidogenic cells. The tissue-specific recruitment of co-factors by SF-1 has been described in several cell types (Hammer & Ingraham 1999) . It is the case, in particular, of early growth response protein 1 in pituitary gonadotropes (Halvorson et al. 1998 ) and Wilm's tumor-associated gene-1 (WT-1) in gonads (Nachtigal et al. 1998) . A crucial role of SF-1 in tissue-specific expression because of interactions with various trancriptional regulators such as WT-1 (Nachtigal et al. 1998 ), SRY-related HMG-box, gene 9 (DeSantaBarbara et al. 1998 and GATA-4 (Tremblay & Viger 1999) Cammas et al. (1997) but no further studies have been done.
The involvement of proteins that bind to an E-box in tissue-specific expression has been described for numerous genes. They play a role in transcription either as activators or as repressors. For example there are two E-boxes in rat skeletal muscle type 1 sodium channel (SkM1) gene (Kraner et al. 1998) . The proximal site which binds a transcription factor belonging to the MyoD family controls the positive expression of the gene in muscle cells, when the more distal site plays a role in the repression of SkM1 expression in non-muscle cells. Proteins that bind to hexanucleotide E-boxes (CANNTG) belongs to the basic helix-loop-helix protein (bHLH) family which is characterized by the presence of two domains: a conserved helix-loop-helix domain allows homo-or heterodimerization and interactions with other proteins (Murre et al. 1994 ) and a basic domain, the paired basic domain permitting binding to the specific DNA sequence. E-box-binding proteins have, in particular, been shown to interact with factors involved in the oxidative stress or in hypoxia (Li et al. 1998 , St-Pierre et al. 2002 .
In our model, the presence of three different protein complexes appeared to depend on the integrity of the E-box in EMSA studies. Complex 'b' was present only using BAC cell extracts, complex 'd' only using B-Gran cell extracts, whereas complex 'c' was present in both cell types but at a higher level in B-Gran cells than in BAC. The intensity of complex 'a1' was also much higher using B-Gran cell extracts than using BAC cell extracts and competition assays demonstrated that the transcription factor AP-4 was part of this complex. This ubiquitously expressed transcription factor belongs to the bHLH family and more specifically to the bHLH-Zip subfamily. The bHLH-Zip proteins contain another dimerization domain, the leucine zipper (Littlewood & Evan 1995) . As such, AP-4 could potentially form dimers with various transcription factors. It was first identified as a ligand for the simian virus SV40 enhancer ) and described as a transcription activator in synergy with AP-1. To date it has mostly been shown to bind enhancer sequences present in several genes such as human proenkephalin (Comb et al. 1988 ) but it could also be involved in repressor activities (Cui et al. 1998) .
As AP-4 is an ubiquitous protein it must interact with cell-specific proteins or permit the binding of these proteins to their target site(s). In the case of the hMC2R gene, it probably interacts with a repressing factor present in non-adrenal cells and/or permits binding in the vicinity of a protein with inhibitory function (B-Gran specific complex 'd' in our study), possibly through an intermediate protein as cofactor (Fig. 9) . Disruption of the E-box will then prevent formation of both AP-4-containing 'a1' complex and 'd' complex and increase the expression of the hMC2R gene in non-adrenal cells. The formation of a complex between bHLH proteins and cofactors has been demonstrated for several gene promoters. The neuro-specific transcription of the vgf gene is dependent on a tripartite region involving an E-box, a CCAAT sequence and a CRE site (Mandolesi et al. 2002) . The proteins which bind to these sites form a multiprotein complex with p300 coactivator.
It is known that the expression of the hMC2R gene is positively regulated by ACTH (Lebrethon et al. 1994) . In BAC cell extracts, only the binding of proteins belonging to the major complex 'b' was increased (by 2-fold) after ACTH treatment. This increase is in the same order of magnitude as the fold stimulation obtained on cAMP-induced activation of the hMC2R gene promoter (Naville et al. 1999) . This adrenal-specific 'b' protein could act by preventing the binding of AP-4 and/or of the repressing factor (part of complex 'd') to their respective binding site, this effect being even more pronounced after ACTH treatment (Fig. 9) . The binding of this protein 'b' was also dependent on the integrity of the E-box possibly because of a direct binding to this site (Fig. 9) .
Downstream of the E-box, there is an additional element, the overlapping putative Oct-binding site, which bound proteins 'a2' independently of the E-box. Its integrity was also required for the presence of 'b', 'c' and 'd' complexes. It could then stabilize formation of a multiprotein complex, in particular in B-Gran cells (Fig. 9 ). In conclusion, we have show here that a proximal region in the hMC2R gene promoter was involved in the partial inhibition of the hMC2R gene expression in non-adrenal cells, but other more distal (upstream of position 2248 bp) element(s) would be needed to completely prevent hMC2R gene expression in these cells. 
